Navigating regulatory and policy challenges for AI enabled combination devices.
PMID: 39669903 ·
S, n, i, g, d, h, a, , S, a, n, t, r, a, ;, , P, r, e, e, t, , K, u, k, r, e, j, a, ;, , K, i, n, s, h, u, k, , S, a, x, e, n, a, ;, , S, a, n, y, a, m, , G, a, n, d, h, i, ;, , O, m, , V, , S, i, n, g, h
Publicidad
Resumen
In recent years, the Artificial Intelligence (AI) has enabled conventional Combination Devices (CDs) to innovate in healthcare merging with technology sectors. However, the challenges like reliance on predicate devices in US Food and Drug Administration (FDA's 510(k) pathway, especially for perpetually updating AI are stressed. Though the European Union (EU's new Medical Device Regulations address software and AI, fitting adaptive algorithms into conformity assessments remains difficult. The urg
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.